2008: Innate Immunity
Search or Browse by Day

Innate Immunity

Tuesday, October 28, 2008
1450
Shift from TLR2 towards TLR4 Dependency in the Erosive Stage of Chronic Experimental Arthritis Coincident with Th17 Development
1451
Reduction in membrane TNF expression in neutrophils from Rheumatoid Arthritis patients following anti-TNF therapy
1452
Autoantibodies to Histones and dsDNA Induced by Syngeneic Late Apoptotic Cells Require MyD88 But Not TLR9
1453
Immune Opsonins Modulate Blys/baff Release In A Receptor-specific Fashion
1454
Full Maturation Of CD8+ T Cell Via Antigen Cross Presentation Into IFNγ-producing Effector Is Prerequisite To The Induction Of Autoimmune Tissue Injury
1455
Membrane Raft (MR) Mobilization by the Membrane Attack Complex (MAC): A key event in T cell receptor activation
1456
Treating Rheumatoid Arthritis By Inhibiting Jak3-stat6; Its Effect On Dendritic Cells
1457
Role of C1q in Regulation of IFN-alpha Production
1458
Antiphospholipid Antibodies induce TLR8 in Monocytes
1459
Antigen-specific Immunotherapy in a Bottle: Liposomes loaded with Antigen and NF-kappaB Inhibitor target Dendritic Cells in vivo for Antigen-specific Tolerance
1460
Protective Crossreactivity Of Rheumatoid Factors With B Cell Stimulatory ssDna Stimulates Toll 9 And May Be Involved In Arthritis Induction
1461
The Pathogenic Role of Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus
1462
Surfactant Protein D is Decreased in Rheumatoid Arthritis
1463
Neutrophil Regulation of Adaptive Immunity: An In Vitro Model Identifies Hubs and Nodes With Similarities to Those Seen in Polyarticular JIA
1464
Differential Regulation of the Interferon Signature in Synoviocytes by MKK3 and MKK6
1465
The Expression of TLR3 and TLR7 in Muscle Tissue is Specific of Inflammatory Myopathy and is Differentially Regulated In Vitro by Th1 and Th17 Cytokines
1466
Toll-Like Receptor-Inducible Upregulation of Alternative IRF5 mRNA Isoforms Correlates with Differential Tissue Targeting in Human Anti-RNP Autoimmunity
1467
Modulation of Behçet´s Disease Polymorphonuclear Leukocyte Chemotaxis by Lipoteichoic Acid and Plasmatic Factors Acts Independently of TLR2 or CD14 Expression on Neutrophils Membrane
1468
FK506 treated Dendritic Cells Skew Antigen Presentation to Tolerance- Groundwork in Tolerogenic Dendritic Cell Vaccines
1469
TLR2 inhibits TLR4 and TLR7/8 Signalling in Dendritic Cells thereby Inducing a Shift From Th1 to Th2 and Th17 Responses
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>